Biotech drugs
What if Europe became a leader in biotech innovation?
Unleashing Europe’s biotech prowess requires radical reinvention
Covid-19 vaccine-maker BioNTech to acquire former rival CureVac
Poland hits a wall trying to curb Big Pharma’s profits
French researchers to Macron: Take care of us before wooing Americans
Europe faces growing threat of fake drugs, Europol warns
Biotechs ‘cry for help’ to fix antibiotics market failure
Everyone’s tough on drugs again
Traffickers are to blame, the candidates say. Virtually no one’s talking about treatment.
Drug prices in Europe are soaring — and are only expected to rise
Cancer and rare disease drugs are pushing up total drug spending across Europe.
These are the most deadly pathogens — so why aren’t drug companies targeting them?
Despite calls to step up efforts, investment in antimicrobial resistance is still insufficient.
EU drugs regulator revises rules after court links experts to industry
A court found flaws in the European Medicines Agency’s policy for handling links to competitor drugs.
Why Big Pharma might think twice about running away to America
A major drug pricing crackdown in the US is threatening drug companies’ bottom lines.
Inflation hits medicines manufacturers, threatens UK supplies
Generic drugmakers with thin margins and locked-in contracts are seeing some products become loss-making.
Ethical concerns as Big Tobacco hustles into health care
Philip Morris International is buying a successful British company making inhaled treatments for lung disease.
Ward closures among UK hospital contingency plans for no-deal Brexit
Planning documents outline potential interruptions to children’s services, Parkinson’s diagnoses and HIV prevention.
EU agency offers free holidays in Amsterdam to help sway staff move
European Medicines Agency’s Brexit point-man says staff retention is looking up.
Health groups warn Brexit drugs supply risk at code ‘red’
NHS providers, companies and patient groups warn of ‘widespread shortages’ if there’s no Brexit deal.
UK pharma chief: EU stance ‘puts patients at risk’ after Brexit
The UK is set to be frozen out of EU schemes to monitor drug safety and infectious diseases.
UK, EU medicines trade groups lobby Barnier, Davis for medicines alignment
Both sides must ensure patients maintain access to safe medicines, groups wrote.
British biotech fears Brexit funding hole
UK on the stingy side in funding early research.